Russia is aiming for an approved COVID-19 vaccine in the next fortnight to portray itself as a global science leader, but there are major concerns over a lack of data and testing
Russiais aiming to have a COVID-19 vaccineapproved for public use by August 10, which would make it the first approved vaccine in the world, Russian officials told CNN.
- Kirill Dmitriev, the head of Russia's sovereign wealth fund, compared the vaccine's quick development to Russia launching the first successful satellite in 1957, beating the US to it.
- "It's a Sputnik moment," he said. "Americans were surprised when they heard Sputnik's beeping. It's the same with this vaccine. Russia will have got there first."
- He also said that scientists had not rushed to be first, but were focused on protecting people in Russia, as cases continued to climb.
- As of July 29, Russia had the fourth most cases in the world, with 822,060 confirmed COVID-19 cases and 13,483 deaths, according to data from Johns Hopkins University.
Russia is gunning to have the world's first
A COVID-19 vaccine, created by the Gamaleya Institute in Moscow, aims to be approved for public use by August 10, then administered to frontline medical workers, while it simultaneously goes through a third phase of tests, Russian officials told CNN.Kirill Dmitriev, the head of Russia's sovereign wealth fund, which funded the vaccine research, compared it to Russia beating the US to launching the first successful satellite in 1957.Advertisement
"It's a Sputnik moment," he said.
Adding: "Americans were surprised when they heard Sputnik's beeping. It's the same with this vaccine. Russia will have got there first."CNN reported that critics said Russia was racing ahead with its vaccine because scientists were under pressure from the Kremlin, which wanted Russia to be seen as a scientific leader. No data has been released and the safety and effectiveness of the vaccine are unknown.
Dmitriev said scientists had not rushed to be first but were focused on protecting people in Russia, as COVID-19 cases continued to climb.As of July 29, Russia had the fourth most cases in the world, with 822,060 confirmed COVID-19 cases, and 13,483 deaths, according to data from Johns Hopkins University. Around the world, there are more than 100 potential vaccines being developed, and at least four of them are in their final human trials, three of those in China, and one in Britain, Reuters reported. Advertisement
Gamaleya Institute's vaccine was developed quickly, according to Russian scientists, because it's based on a modified vaccine that's been used for different diseases, which is not unusual.
Some of the other vaccines that are being worked on around the world are currently in their third phase of testing, but Russia's vaccine is still on its second phase, which is expected to be done by August 3.The third testing phase will take place at the same time as medical workers get vaccinated. It will require an additional shot, which is unlike a lot of vaccines, according to CNN.Advertisement
Russia's health ministry had not confirmed August 10 as the aimed-for date, but The Moscow Times reported earlier in the week that the government's plan was to administer its vaccine on healthcare workers before clinical trials had been completed, sometime in August.
Russian health minister Mikhail Murashko said 800 people would take part in stage three trials, and at the same time scaling and production would begin, resulting in "large-scale production and large-scale application," he said.Russian officials said that the data behind the vaccine would be available for review and publication early next month. Advertisement
- Encounter underway in Jammu and Kashmir's Kulgam
- INTERVIEW: Tech Mahindra CFO says lateral hiring will take time — and only after utilisation improves to pre-COVID levels
- Zomato announces 10 days of menstrual leave for all women employees – including transgender people
- Mukesh Ambani is now the world’s fourth-richest person after he beat Louis Vuitton owner Bernard Arnault
- If you have a high risk tolerance — here are a few ‘aggressive’ investment bets to consider